- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05035719
Comparison Studies Comparing Hemodynamic Parameters Provided by the Caretaker Against Respective Gold Standard References
September 1, 2021 updated by: CareTaker Medical LLC
Comparison Studies Comparing Hemodynamic Parameters Provided by the Caretaker
Comparison studies comparing hemodynamic parameters provided by the Caretaker against respective Gold Standard references.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
Comparison study comparing hemodynamic parameters provided by the Caretaker against respective Gold Standard references.
Specifically, continuous beat-by-beat blood pressure readings against arterial catheter readings and cardiac output (CO) and stroke volume (SV) measures against thermo-dilution measurements
Study Type
Observational
Enrollment (Anticipated)
60
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Martin C Baruch, PhD
- Phone Number: 103 434 978-7000
- Email: martin@caretakermedical.net
Study Locations
-
-
New Jersey
-
Camden, New Jersey, United States, 08103
- Recruiting
- Cooper University Hospital
-
Contact:
- Irwin Gratz, DO
- Phone Number: 856-342-2425
- Email: GRATZ-IRWIN@cooperhealth.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Cardiac patients
Description
Inclusion Criteria:
- 18 years of age
- able and willing to participate
- provide written consent
Exclusion Criteria:
- Unable to give written consent
- <18 years of age
- No or poor finger pulse, as determined through visual inspection for ischemic hands
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Group 1
Cardiac patients
|
Equivalence of Caretaker cardiac output reading to reference standard
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiac output performance comparison
Time Frame: Change between several paired readings over the course of cardiac surgery (typically 2-4 hours)
|
Comparison with thermo-dilution-based cardiac output, agreement within 1 l/min.
|
Change between several paired readings over the course of cardiac surgery (typically 2-4 hours)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 1, 2021
Primary Completion (Anticipated)
March 31, 2022
Study Completion (Anticipated)
March 31, 2022
Study Registration Dates
First Submitted
August 31, 2021
First Submitted That Met QC Criteria
September 1, 2021
First Posted (Actual)
September 5, 2021
Study Record Updates
Last Update Posted (Actual)
September 5, 2021
Last Update Submitted That Met QC Criteria
September 1, 2021
Last Verified
August 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Hemo_002
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiac Output, Low
-
HeartBeat Technologies LTDUnknownLow Cardiac Output | High Cardiac OutputIsrael
-
Cairo UniversityNot yet recruitingDobutamine, Milrinone , Pediatrics , Low Cardiac OutputEgypt
-
University of LiegeCompletedLow Cardiac Output Syndrome After Adult Cardiac Surgery
-
Bozyaka Training and Research HospitalBaşakşehir Çam & Sakura City HospitalNot yet recruitingPerfusion Index and Cerebral NIRS Trends in Low Cardiac Output Syndrome
-
University of IowaCompletedLow Cardiac OutputUnited States
-
University of AberdeenCompletedLow Cardiac OutputUnited Kingdom
-
Innogene Kalbiotech Pte. LtdCompletedLow Cardiac OutputIndonesia
-
University of RochesterNational Institutes of Health (NIH)WithdrawnLow Cardiac OutputUnited States
-
Innogene Kalbiotech Pte. LtdCompletedLow Cardiac OutputIndonesia
Clinical Trials on non-invasive cardiac output monitor
-
Mayo ClinicCompleted
-
Cairo UniversityCompleted
-
Hospital for Special Surgery, New YorkCompleted
-
Massachusetts General HospitalUnknownGeneral Anesthesia | General Surgery | Pediatrics | Cardiac Output | Anesthesiology | OrthopedicsUnited States
-
Charite University, Berlin, GermanyUnknownPostoperative Wound Infection | Postoperative OutcomeGermany
-
Edwards LifesciencesCompletedCardiac Output, Low | Cardiac Output, HighSwitzerland, Finland
-
Universitätsmedizin MannheimUnknownHeart Failure | Sepsis | Respiratory Failure | Renal FailureGermany
-
Mai XiaoweiGuangzhou Panyu Central HospitalCompleted
-
Imperial College Healthcare NHS TrustRecruitingBlood Pressure | Cardiac Output, Low | Cardiac Output, HighUnited Kingdom